NCT02013544 - Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause | Biotech Hunter

Enrollment

558

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions

Vaginal Atrophy

Interventions

DRUG

Placebo

DRUG

Prasterone (DHEA)

Trial Locations (38)

21093

EndoCeutics site # 27, Lutherville

23507

EndoCeutics site # 03, Norfolk

30328

EndoCeutics site # 23, Atlanta

33161

EndoCeutics site # 54, North Miami

33409

EndoCeutics site # 80, West Palm Beach

33461

EndoCeutics site # 60, Lake Worth

33472

EndoCeutics site # 45, Boynton Beach

36117

EndoCeutics site # 39, Montgomery

40291

EndoCeutics site # 86, Louisville

43213

EndoCeutics site # 15, Columbus

44122

EndoCeutics site # 05, Cleveland

67226

EndoCeutics site # 55, Wichita

77030

EndoCeutics site # 82, Houston

78414

EndoCeutics site # 84, Corpus Christi

80209

EndoCeutics site # 36, Denver

80220

EndoCeutics site # 52, Denver

85712

EndoCeutics site # 14, Tucson

92103

EndoCeutics site # 83, San Diego

92108

EndoCeutics site # 30, San Diego

95821

EndoCeutics site # 21, Sacramento

98105

EndoCeutics site # 76, Seattle

08648

EndoCeutics site # 87, Lawrenceville

08536

EndoCeutics site # 81, Plainsboro

19114-1029

EndoCeutics site # 75, Philadelphia

L7R 4B8

EndoCeutics site # 85, Burlington

N0N1G0

EndoCeutics site # 69, Corunna

N7T 4X3

EndoCeutics site # 68, Sarnia

N2J 1C4

EndoCeutics site # 73, Waterloo

J2B 7T1

EndoCeutics site # 04, Drummondville

H4N 3C5

EndoCeutics site # 12, Montreal

H9R 4S3

EndoCeutics site # 79, Pointe-Claire

G1S 2L6

EndoCeutics site # 02, Québec

G1V 2L9

EndoCeutics site # 01, Québec

G1W 4R4

EndoCeutics site # 77, Québec

G3K 2P8

EndoCeutics site # 78, Québec

G6W 5M6

EndoCeutics site # 18, Saint Romuald

J1J 2G2

EndoCeutics site # 74, Sherbrooke

G6P 6P6

EndoCeutics site # 67, Victoriaville